FBR Capital Raises Price Target on Harman (HAR) to $90 Following 4Q

Piper Jaffray Remains Sidelined on Harmon International (HAR) Despite Strong Q4; PT to $88

August 5, 2016 8:59 AM EDT

Piper Jaffray analyst Alexander Potter reiterated a Neutral rating but raised its price target on Harmon International (NYSE: HAR) to $88.00 (from $84.00) following strong Q4.

Potter commented, "We remain Neutral following a generally strong 4Q16 result. Notably, 12% EBITDA margins in the Professional... More

Baird Downgrades Harmon International (HAR) to Neutral

August 5, 2016 7:49 AM EDT

Baird downgraded Harmon International (NYSE: HAR) from Outperform to Neutral with a price target of $87 (unchanged).

For an analyst ratings summary and ratings history on Harmon International click here. For more ratings news on Harmon International click here.

Shares of Harmon International closed at $87.54 yesterday.

... More

Harman (HAR) Tops Q4 EPS by 5c

August 4, 2016 8:15 AM EDT

Harman (NYSE: HAR) reported Q4 EPS of $1.57, $0.05 better than the analyst estimate of $1.52. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.78 billion.

GUIDANCE:

Harman sees FY2017 EPS of $6.75-$7.00, versus the consensus of $6.80. Harman sees... More

Trading Radar for 8/4: Kellogg (K), MGM Resorts (MGM), Activision (ATVI), FireEye (FEYE), Weight Watchers (WTW) Report

August 3, 2016 2:51 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 264kContinuing Claims - no Street consensus

Earnings:

AAC Holdings (NYSE: AAC) - consensus EPS $0.23
AGCO Corp. (Nasdaq: AGCO) - consensus EPS $0.92
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.77
Acceleron Pharma (NYSE: XLRN) - consensus loss $0.50
Agios Pharma (Nasdaq:... More